본문 바로가기
KERD
논문KCI 등재

Biological Aspects of Aggression and Violence in Schizophrenia

이상혁|안이슬|Minji Bang|WonKyung Cho|Won-Suk Shin|Doo-Yeoun Cho
대한정신약물학회 (Korean College of Neuropsychopharmacology)|2019.11|Clinical Psychopharmacology and Neuroscience|제17권 제4호|pp. 475-486|DOI https://doi.org/10.9758/cpn.2019.17.4.475

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

SchizophreniaAggressionViolenceNeuroimagingAntipsychotic agents.

초록

Although the majority of patients with schizophrenia are not actually violent, an increased tendency toward violent behaviors is known to be associated with schizophrenia. There are several factors to consider when identifying the subgroup of patients with schizophrenia who may commit violent or aggressive acts. Comorbidity with substance abuse is the most important clinical indicator of increased aggressive behaviors and crime rates in patients with schizophrenia. Genetic studies have proposed that polymorphisms in the promoter region of the serotonin transporter gene and in the catechol-O-methyltransferase gene are related to aggression. Neuroimaging studies have suggested that fronto-limbic dysfunction may be related to aggression or violence. By identifying specific risk factors, a more efficient treatment plan to prevent violent behavior in schizophrenia will be possible. Management of comorbid substance use disorder may help prevent violent events and overall aggression. Currently, clozapine may be the only effective antipsychotic medication to repress aggressive behavior. With the current medical field moving toward tailored medicine, it is important to identify vulnerable schizophrenia populations and provide efficient treatment.

Abstract

Although the majority of patients with schizophrenia are not actually violent, an increased tendency toward violent behaviors is known to be associated with schizophrenia. There are several factors to consider when identifying the subgroup of patients with schizophrenia who may commit violent or aggressive acts. Comorbidity with substance abuse is the most important clinical indicator of increased aggressive behaviors and crime rates in patients with schizophrenia. Genetic studies have proposed that polymorphisms in the promoter region of the serotonin transporter gene and in the catechol-O-methyltransferase gene are related to aggression. Neuroimaging studies have suggested that fronto-limbic dysfunction may be related to aggression or violence. By identifying specific risk factors, a more efficient treatment plan to prevent violent behavior in schizophrenia will be possible. Management of comorbid substance use disorder may help prevent violent events and overall aggression. Currently, clozapine may be the only effective antipsychotic medication to repress aggressive behavior. With the current medical field moving toward tailored medicine, it is important to identify vulnerable schizophrenia populations and provide efficient treatment.

참고문헌 (102)

  1. Brown SR, "Blunt rupture of the thoracic duct after severe thoracic trauma", Trauma Surg Acute Care Open, 3, pp.e000183~ (2018)
  2. Prins SJ, "Prevalence of mental illnesses in US State prisons : a systematic review", Psychiatr Serv, 65, pp.862~872 (2014)
  3. Fazel S, "Mental health of prisoners : prevalence, adverse outcomes, and interventions", Lancet Psychiatry, 3, pp.871~881 (2016)
  4. Tiihonen J, "Specific major mental disorders and criminality : a 26-year prospective study of the 1966 northern Finland birth cohort", Am J Psychiatry, 154, pp.840~845 (1997)
  5. Lindqvist P, "Schizophrenia and crime. A longitudinal follow-up of 644 schizophrenics in Stockholm", Br J Psychiatry, 157, pp.345~350 (1990)
  6. Schenk AM, "Individual characteristics related to prison violence : a critical review of the literature", Aggress Violent Behav, 17, pp.430~442 (2012)
  7. Houser KA, "Examining the association between co-occurring disorders and seriousness of misconduct by female prison inmates", Crim Justice Behav, 41, pp.650~666 (2014)
  8. James DJ, "Mental health problems of prison and jail inmates" (2006), US Department of Justice
  9. Hassan L, "Prospective cohort study of mental health during imprisonment", Br J Psychiatry, 198, pp.37~42 (2011)
  10. Christian CJ, "Major mental disorders and violence : a critical update", Curr Psychiatry Rev, 3, pp.33~50 (2007)
  11. Kooyman I, "Outcomes of public concern in schizophrenia", Br J Psychiatry Suppl, 50, pp.s29~s36 (2007)
  12. Arseneault L, "Mental disorders and violence in a total birth cohort : results from the Dunedin Study", Arch Gen Psychiatry, 57, pp.979~986 (2000)
  13. Wallace C, "Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders", Am J Psychiatry, 161, pp.716~727 (2004)
  14. Steadman HJ, "Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods", Arch Gen Psychiatry, 55, pp.393~401 (1998)
  15. Fazel S, "Schizophrenia, substance abuse, and violent crime", JAMA, 301, pp.2016~2023 (2009)
  16. Lehman AF, "Practice guideline for the treatment of patients with schizophrenia, second edition", Am J Psychiatry, 161, pp.1~56 (2004)
  17. Cantor-Graae E, "Substance abuse in schizophrenia : a review of the literature and a study of correlates in Sweden", Schizophr Res, 48, pp.69~82 (2001)
  18. Räsänen P, "Schizophrenia, alcohol abuse, and violent behavior : a 26-year followup study of an unselected birth cohort", Schizophr Bull, 24, pp.437~441 (1998)
  19. Krakowski M, "Course of violence in patients with schizophrenia : relationship to clinical symptoms", Schizophr Bull, 25, pp.505~517 (1999)
  20. Cuffel BJ, "A longitudinal study of substance use and community violence in schizophrenia", J Nerv Ment Dis, 182, pp.704~708 (1994)
  21. Fazel S, "Schizophrenia and violence : systematic review and meta-analysis", PLoS Med, 6, pp.e1000120~ (2009)
  22. Swanson JW, "A national study of violent behavior in persons with schizophrenia", Arch Gen Psychiatry, 63, pp.490~499 (2006)
  23. Koen L, "Violence in male patients with schizophrenia : risk markers in a South African population", Aust N Z J Psychiatry, 38, pp.254~259 (2004)
  24. Caqueo-Urízar A, "Violent behavior and aggression in schizophrenia: prevalence and risk factors. A multicentric study from three Latin-America countries", Schizophr Res, 178, pp.23~28 (2016)
  25. Fresán A, "Temperament and character in violent schizophrenic patients", Schizophr Res, 94, pp.74~80 (2007)
  26. Wong M, "Repetitive and non-repetitive violent offending behaviour in male patients in a maximum security mental hospital--clinical and neuroimaging findings", Med Sci Law, 37, pp.150~160 (1997)
  27. Volkow ND, "Substance use disorders in schizophrenia--clinical implications of comorbidity", Schizophr Bull, 35, pp.469~472 (2009)
  28. Dalley JW, "Nucleus accumbens D2", 3 receptors predict trait impulsivity and cocaine reinforcement, 2007, pp.315, 1267~1270
  29. Everitt BJ, "Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction", Philos Trans R Soc Lond B Biol Sci, 363, pp.3125~3135 (2008)
  30. Brady KT, "The relationship between substance use disorders, impulse control disorders, and pathological aggression", Am J Addict, 7, pp.221~230 (1998)
  31. Cuomo C, "Aggression, impulsivity, personality traits, and childhood trauma of prisoners with substance abuse and addiction", Am J Drug Alcohol Abuse, 34, pp.339~345 (2008)
  32. Sánchez-Martín JR, "Relating testosterone levels and free play social behavior in male and female preschool children", Psychoneuroendocrinology, 25, pp.773~783 (2000)
  33. van Bokhoven I, "Salivary testosterone and aggression, delinquency, and social dominance in a population-based longitudinal study of adolescent males", Horm Behav, 50, pp.118~125 (2006)
  34. Dabbs JM Jr, "Salivary testosterone and cortisol among late adolescent male offenders", J Abnorm Child Psychol, 19, pp.469~478 (1991)
  35. Booth A, "The influence of testosterone on deviance in adulthood : assessing and explaining the relationship*", Criminol, 31, pp.93~117 (1993)
  36. Räsänen P, "Serum testosterone levels, mental disorders and criminal behaviour", Acta Psychiatr Scand, 99, pp.348~352 (1999)
  37. Moore L, "Serum testosterone levels are related to cognitive function in men with schizophrenia", Psychoneuroendocrinology, 38, pp.1717~1728 (2013)
  38. Taherianfard M, "Evaluation of serum steroid hormones in schizophrenic patients", Indian J Med Sci, 58, pp.3~9 (2004)
  39. Huber TJ, "Sex hormones in psychotic men", Psychoneuroendocrinology, 30, pp.111~114 (2005)
  40. Ko YH, "Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia", Psychoneuroendocrinology, 32, pp.385~391 (2007)
  41. Sisek-Šprem M, "Testosterone levels and clinical features of schizophrenia with emphasis on negative symptoms and aggression", Nord J Psychiatry, 69, pp.102~109 (2015)
  42. Saad F, "The role of testosterone in the metabolic syndrome : a review", J Steroid Biochem Mol Biol, 114, pp.40~43 (2009)
  43. Goncharov NP, "Three definitions of metabolic syndrome applied to a sample of young obese men and their relation with plasma testosterone", Aging Male, 11, pp.118~122 (2008)
  44. Okonmah AD, "The effect of neuroleptic drugs on serum testosterone level in the male rat", Gen Pharmacol, 17, pp.235~238 (1986)
  45. Fernandez-Egea E, "Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis : a test of the accelerated aging hypothesis", Psychosom Med, 73, pp.643~647 (2011)
  46. Miles DR, "Genetic and environmental architecture of human aggression", J Pers Soc Psychol, 72, pp.207~217 (1997)
  47. Higley JD, "CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors", Biol Psychiatry, 40, pp.1067~1082 (1996)
  48. Birger M, "Aggression : the testosterone-serotonin link", Isr Med Assoc J, 5, pp.653~658 (2003)
  49. Coccaro EF, "Serotonin function in human subjects : intercorrelations among central 5-HT indices and aggressiveness", Psychiatry Res, 73, pp.1~14 (1997)
  50. Nolan KA, "An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorder", Psychiatr Genet, 10, pp.109~115 (2000)
  51. Han DH, "Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltransferase genes", Psychiatry Res, 129, pp.29~37 (2004)
  52. Volavka J, "Catecholamines and aggression : the role of COMT and MAO polymorphisms", Ann N Y Acad Sci, 1036, pp.393~398 (2004)
  53. Jones PB, "Randomized controlled trial of the effect on Quality of Life of second-vs first-generation antipsychotic drugs in schizophrenia : Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study(CUtLASS 1)", Arch Gen Psychiatry, 63, pp.1079~1087 (2006)
  54. Tosato S, "Effect of COMT genotype on aggressive behaviour in a community cohort of schizophrenic patients", Neurosci Lett, 495, pp.17~21 (2011)
  55. Kim YR, "Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population", Eur Neuropsychopharmacol, 18, pp.820~825 (2008)
  56. Han DH, "Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients", Neuroreport, 17, pp.95~99 (2006)
  57. Park TW, "Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia", Eur Neuropsychopharmacol, 12, pp.299~303 (2002)
  58. Liou YJ, "Association analysis of a functional catechol-o-methyltransferase gene polymorphism in schizophrenic patients in Taiwan", Neuropsychobiology, 43, pp.11~14 (2001)
  59. Lachman HM, "Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder", Am J Psychiatry, 155, pp.835~837 (1998)
  60. Guan X, "Lack of association between brain-derived neurotrophic factor Val66Met polymorphism and aggressive behavior in schizophrenia", Psychiatry Res, 215, pp.244~245 (2014)
  61. Chung S, "Association among aggressiveness, neurocognitive function, and the Val66Met polymorphism of brain-derived neurotrophic factor gene in male schizophrenic patients", Compr Psychiatry, 51, pp.367~372 (2010)
  62. Koh KB, "The relation of serotonin-related gene and COMT gene polymorphisms with criminal behavior in schizophrenic disorder", J Clin Psychiatry, 73, pp.159~163 (2012)
  63. Gu Y, "Association between COMT gene and Chinese male schizophrenic patients with violent behavior", Med Sci Monit, 15, pp.CD484~CD489 (2009)
  64. Hong JP, "New functional single nucleotide polymorphism (Ala72Ser) in the COMT gene is associated with aggressive behavior in male schizophrenia", Am J Med Genet B Neuropsychiatr Genet, 147B, pp.658~660 (2008)
  65. Zammit S, "Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia", Am J Med Genet B Neuropsychiatr Genet, 28, pp.19~20 (2004)
  66. Strous RD, "Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study", Am J Med Genet B Neuropsychiatr Genet, 120B, pp.29~34 (2003)
  67. Kim YR, "Association between the serotonin transporter gene(5-HTTLPR)and anger-related traits in Korean schizophrenic patients", Neuropsychobiology, 59, pp.165~171 (2009)
  68. Fresan A, "Association study of MAO-A and DRD4 genes in schizophrenic patients with aggressive behavior", Neuropsychobiology, 55, pp.171~175 (2007)
  69. Kotler M, "Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase(COMT)activity", Am J Med Genet, 88, pp.628~633 (1999)
  70. Tsai SJ, "Association study of serotonin-6 receptor variant(C267T)with schizophrenia and aggressive behavior", Neurosci Lett, 271, pp.135~137 (1999)
  71. Vassos E, "Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression", Mol Psychiatry, 19, pp.471~477 (2014)
  72. Hoptman MJ, "Neuroimaging correlates of aggression in schizophrenia : an update", Curr Opin Psychiatry, 24, pp.100~106 (2011)
  73. Dolan MC, "Psychopathy and functional magnetic resonance imaging blood oxygenation level-dependent responses to emotional faces in violent patients with schizophrenia", Biol Psychiatry, 66, pp.570~577 (2009)
  74. Hoptman MJ, "Amygdalofrontal functional disconnectivity and aggression in schizophrenia", Schizophr Bull, 36, pp.1020~1028 (2010)
  75. Kumari V, "Dysfunctional, but not functional, impulsivity is associated with a history of seriously violent behaviour and reduced orbitofrontal and hippocampal volumes in schizophrenia", Psychiatry Res, 173, pp.39~44 (2009)
  76. Puri BK, "Regional grey matter volumetric changes in forensic schizophrenia patients: an MRI study comparing the brain structure of patients who have seriously and violently offended with that of patients who have not", BMC Psychiatry, 8(Suppl 1), pp.S6~ (2008)
  77. Hoptman MJ, "Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder", J Neuropsychiatry Clin Neurosci, 18, pp.509~515 (2006)
  78. Rüsch N, "Inferior frontal white matter volume and suicidality in schizophrenia", Psychiatry Res, 164, pp.206~214 (2008)
  79. Hoptman MJ, "Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder", Psychiatry Res, 140, pp.133~145 (2005)
  80. Barkataki I, "Volumetric structural brain abnormalities in men with schizophrenia or antisocial personality disorder", Behav Brain Res, 169, pp.239~247 (2006)
  81. Hoptman MJ, "Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia : a preliminary study", Biol Psychiatry, 52, pp.9~14 (2002)
  82. Kumari V, "Neural and behavioural responses to threat in men with a history of serious violence and schizophrenia or antisocial personality disorder", Schizophr Res, 110, pp.47~58 (2009)
  83. Kumari V, "Neural dysfunction and violence in schizophrenia : an fMRI investigation", Schizophr Res, 84, pp.144~164 (2006)
  84. Joyal CC, "Violent persons with schizophrenia and comorbid disorders : a functional magnetic resonance imaging study", Schizophr Res, 91, pp.97~102 (2007)
  85. Wong MT, "Positron emission tomography in male violent offenders with schizophrenia", Psychiatry Res, 68, pp.111~123 (1997)
  86. Spalletta G, "Reduced prefrontal cognitive activation associated with aggression in schizophrenia", Schizophr Res, 50, pp.134~135 (2001)
  87. Fjellvang M, "Imaging violence in schizophrenia : a systematic review and critical discussion of the MRI literature", Front Psychiatry, 9, pp.333~ (2018)
  88. Swanson JW, "Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia", Br J Psychiatry, 193, pp.37~43 (2008)
  89. Buckley PF, "Clozapine treatment of schizophrenia : implications for forensic psychiatry", J Clin Forensic Med, 2, pp.9~16 (1995)
  90. Krakowski MI, "Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder", Arch Gen Psychiatry, 63, pp.622~629 (2006)
  91. Swanson JW, "Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment", Schizophr Bull, 30, pp.3~20 (2004)
  92. Lieberman JA, "Effectiveness of antipsychotic drugs in patients with chronic schizophrenia", N Engl J Med, 353, pp.1209~1223 (2005)
  93. Tiihonen J, "Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder : observational follow-up study", BMJ, 333, pp.224~ (2006)
  94. Buckley P, "Psychopharmacology of aggression in schizophrenia", Schizophr Bull, 37, pp.930~936 (2011)
  95. Rabinowitz J, "Effect of clozapine on physical and verbal aggression", Schizophr Res, 22, pp.249~255 (1996)
  96. Volavka J, "Clozapine effects on hostility and aggression in schizophrenia", J Clin Psychopharmacol, 13, pp.287~289 (1993)
  97. Volavka J, "The effects of clozapine on aggression and substance abuse in schizophrenic patients", J Clin Psychiatry, 60(Suppl 12), pp.43~46 (1999)
  98. Allen MH, "The expert consensus guideline series. Treatment of behavioral emergencies 2005", J Psychiatr Pract, 11(Suppl 1), pp.5~108 (2005)
  99. Cramer JA, "Compliance with medication regimens for mental and physical disorders", Psychiatr Serv, 49, pp.196~201 (1998)
  100. Valenstein M, "Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness", Schizophr Bull, 37, pp.727~736 (2011)
  101. Seon-Cheol Park, "Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis", Clinical Psychopharmacology and Neuroscience, 16(4), pp.361~375 (2018), 대한정신약물학회[DOI]
  102. Awad AG, "Revisiting the ‘self-medication’ hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behavior", Ther Adv Psychopharmacol, 5, pp.172~178 (2015)

관련 논문AI추천

조현병 환자에서 폭력성의 관련요인박선철, 최준호대한조현병학회 · 대한조현병학회지2015 · 제18권 제1호No Evidence of an Association between A218C Polymorphism of the Tryptophan Hydroxylase 1 Gene and Aggression in Schizophrenia in a Korean Population김율리, 민성길, 이주영연세대학교의과대학 · Yonsei Medical Journal2010 · 제51권 제1호Schizophrenia with Obsessive-Compulsive Features: Review of Clinical and Conceptual IssuesJun Soo Kwon, Michael Y. Hwang, Sun Young Yum대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2009 · 제7권 제1호공격적 행위와 조현병에 대한 기분조절제의 효과에 대한 고찰강웅구, 노효성대한신경정신의학회 · 신경정신의학2025 · 제64권 제1호범죄로 수감중인 국내 조현병 환자의 충동적 공격성과 계획적 공격성의 특성 비교권준수, 김민아, 이태영, 임경옥, 조용우대한조현병학회 · 대한조현병학회지2021 · 제24권 제1호Cognitive Deficits in Schizophrenia: Understanding the Biological Correlates and Remediation StrategiesAdarsh Tripathi, Rashmi Shukla, Sujita Kumar Kar대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2018 · 제16권 제1호

이 간행물의 다른 논문 (14건)

Heart and Brain Interaction of Psychiatric Illness: A Review Focused on Heart Rate Variability, Cognitive Function, and Quantitative ElectroencephalographyWookyoung Jung, Kuk-In Jang, Seung-Hwan Leepp. 459-474The Interaction of Oxytocin and Social Support, Loneliness, and Cortisol Level in Major DepressionYen Kuang Yang, Mei Hung Chi, Tsung-Yu Tsai, Hui Hua Chang, Cheng-Kuan Wu, Huai-Hsuan Tseng, Po See Chenpp. 487-494The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective StudySoo-Jung Lee, Ashwin A Patkar, Chi Un Pae, Changsu Han, Won-Myong Bahk, Prakash S Masand, Sheng Min Wangpp. 495-502Difference in Cognitive Function by First Onset Age of Alcohol Induced Blackout and Its DurationBia Seo, Ji-Hun Park, Sung-Young Huh, Eun-Jeong Min, Sung Gon Kim, Jin Seong Lee, Woo-Young Jung, Chang-Hee Hong, Hee Jung Yupp. 503-508Altered Auditory P300 Performance in Parents with Attention Deficit Hyperactivity Disorder OffspringChing-Lin Chu, Mei Hung Chi, Yi-Ting Hsieh, Ko Chin Chen, Yen Kuang Yang, Po See Chen, I Hui Leepp. 509-516
원문 보기